Published in Blood on July 01, 1976
Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A (1985) 2.33
Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica (2011) 1.71
Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol (2008) 1.49
Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia. Blood (2011) 1.41
Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis. Haematologica (2009) 1.20
Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. J Clin Invest (1977) 1.10
Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax (1984) 1.03
Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age. Biol Blood Marrow Transplant (2010) 0.98
Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation. Bone Marrow Transplant (2013) 0.94
Identification and functional characterization of novel telomerase variant alleles in Japanese patients with bone-marrow failure syndromes. Blood Cells Mol Dis (2007) 0.92
Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemia. Haematologica (2009) 0.90
Regulation of human megakaryocytopoiesis. An in vito analysis. J Clin Invest (1981) 0.89
Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC). Pediatr Blood Cancer (2013) 0.88
Gene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cells. PLoS One (2012) 0.87
Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia. Bone Marrow Transplant (2014) 0.87
Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature. Int J Clin Exp Pathol (2014) 0.84
Severe aplastic anaemia following the use of hair dye: report of two cases and review of literature. Postgrad Med J (1985) 0.84
Should we still use Camitta's criteria for severe aplastic anemia? Korean J Hematol (2012) 0.83
Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia. J Immunol (2016) 0.82
Imbalanced expression of T-bet and T cell immunoglobulin mucin-3 in patients with aplastic anaemia. J Clin Immunol (2013) 0.82
Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study. Br J Cancer (1984) 0.81
Total lymphoid irradiation based conditioning for hematopoietic stem cell transplantation in severe aplastic anemia. Radiat Oncol J (2012) 0.81
Pathophysiology and treatment of aplastic anemia. Wien Klin Wochenschr (2003) 0.81
Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders. J Adv Res (2014) 0.80
Bone marrow transplantation: a review. J Natl Med Assoc (1989) 0.79
Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia: a single center experience from China. PLoS One (2014) 0.79
A plasma microRNA signature as a biomarker for acquired aplastic anemia. Haematologica (2016) 0.79
Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD? Bone Marrow Transplant (2016) 0.78
Identification of novel microRNA signatures linked to acquired aplastic anemia. Haematologica (2015) 0.78
Long-term follow-up of Fanconi anemia: clinical manifestation and treatment outcome. Korean J Pediatr (2014) 0.77
The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure. Oncologist (2014) 0.77
Altered expression of T cell Immunoglobulin-Mucin (Tim) molecules in peripheral blood mononuclear cells in aplastic anemia. Cancer Cell Int (2014) 0.76
Impaired Autophagy in Adult Bone Marrow CD34+ Cells of Patients with Aplastic Anemia: Possible Pathogenic Significance. PLoS One (2016) 0.76
Anemia of Central Origin. Semin Hematol (2015) 0.76
De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin. Medicine (Baltimore) (2017) 0.75
Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia. Drug Des Devel Ther (2014) 0.75
Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study. PLoS One (2015) 0.75
Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation. Bone Marrow Transplant (2015) 0.75
Reduced IL-33 plasma levels in aplastic anemia. Cancer Cell Int (2015) 0.75
Correlation analysis of severe aplastic anemia immunosuppressive therapy and human leukocyte antigen alleles in pediatric patients. Exp Ther Med (2015) 0.75
Alternative Donor Transplantation with High-Dose Post-Transplant Cyclophosphamide for Refractory Severe Aplastic Anemia. Biol Blood Marrow Transplant (2016) 0.75
Survival in primary a plastic anaemia; experience with 20 cases from a tertiary hospital in Nigeria. Afr Health Sci (2009) 0.75
Dysregulated miR34a/diacylglycerol kinase ζ interaction enhances T-cell activation in acquired aplastic anemia. Oncotarget (2017) 0.75
Dynamics of Graft Function Measured by DNA-Technology in a Patient with Severe Aplastic Anemia and Repeated Stem Cell Transplantation. Case Rep Med (2014) 0.75
Study of Aplastic Anaemia with Cyclosporine in Resource Poor Setting. J Clin Diagn Res (2016) 0.75
Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors. Br Med J (Clin Res Ed) (1982) 0.75
Changed outlook in aplastic anaemia. Br Med J (1977) 0.75
Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity. Asian J Transfus Sci (2015) 0.75
Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol (2017) 0.75
Incidence and clinical characteristics of clonal cytogenetic abnormalities of acquired aplastic anemia in adults. Korean J Hematol (2010) 0.75
A novel autologous stem cell procedure for the treatment of aplastic anaemia using reprogrammed mature adult cells: a pilot study. Indian J Med Res (2012) 0.75
Incidence and outcome of acquired aplastic anemia-real-world data from patients diagnosed in Sweden from 2000-2011. Haematologica (2017) 0.75
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation (1974) 10.91
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med (1995) 10.04
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature (1985) 8.32
Positive and negative elements regulate human interleukin 3 expression. Proc Natl Acad Sci U S A (1990) 7.44
Graft-versus-leukemia reactions after bone marrow transplantation. Blood (1990) 7.11
Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med (1968) 6.91
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med (2001) 5.59
Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med (1994) 5.32
Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature (1984) 5.10
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol (1997) 4.52
Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion. N Engl J Med (1978) 4.34
Leukocyte oxidase: defective activity in chronic granulomatous disease. Science (1967) 4.25
Bone-marrow transplantation (second of two parts). N Engl J Med (1975) 4.11
Bone marrow transplantation for sickle cell disease. N Engl J Med (1996) 4.02
A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet (1979) 4.01
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell (1986) 3.59
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med (1979) 3.59
Bone marrow transplantation after the Chernobyl nuclear accident. N Engl J Med (1989) 3.46
Cell wall composition and virulence in Escherichia coli. J Exp Med (1968) 3.36
Bone-marrow transplantation (first of two parts). N Engl J Med (1975) 3.33
Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis (1986) 3.31
Cord-blood-cell transplantation--a real sleeper? N Engl J Med (1995) 3.29
Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med (1994) 3.26
Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun (1982) 3.22
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med (1986) 3.22
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol (1990) 3.19
Iron Metabolism. Heme Synthesis in Vitro by Immature Erythrocytes. Science (1949) 3.14
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood (1981) 3.03
Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc (1974) 2.95
Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood (1994) 2.93
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
The canine major histocompatibility complex. Supertypic specificities defined by the primed lymphocyte test (PLT). Immunogenetics (1984) 2.72
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med (1981) 2.61
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med (1983) 2.53
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med (1996) 2.52
Globin chain synthesis in the alpha thalassemia syndromes. J Clin Invest (1969) 2.46
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest (1984) 2.43
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med (1989) 2.42
The molecular basis of alpha-thalassemias: frequent occurrence of dysfunctional alpha loci among non-Asians with Hb H disease. Cell (1979) 2.41
Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol (2000) 2.40
Treatment of Cooley's anemia. Blood (1990) 2.40
Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis (1983) 2.39
Disorders of phagocytic cell function. Prog Hematol (1971) 2.37
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36
Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature (1986) 2.36
Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro. J Exp Med (1978) 2.33
Continuous subcutaenous administration of deferoxamine in patients with iron overload. N Engl J Med (1977) 2.31
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood (1996) 2.30
Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med (1985) 2.30
Clinical uses of intravenous immunoglobulins. Ann Intern Med (1990) 2.29
T-cell depletion of HLA-identical transplants in leukemia. Blood (1991) 2.25
Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol (1988) 2.24
Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (1976) 2.23
Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology (1984) 2.19
Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med (1988) 2.19
Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol (2003) 2.15
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood (1992) 2.14
Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines. Blood (1989) 2.13
Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet (1972) 2.13
Abnormalities in the mechanical properties of red blood cells caused by Plasmodium falciparum. Blood (1989) 2.12
Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci U S A (1993) 2.12
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood (1993) 2.12
Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. J Clin Invest (1969) 2.11
Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. Ann Intern Med (1980) 2.11
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant (2001) 2.10
A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis (1977) 2.10
Progressive telomere shortening in aplastic anemia. Blood (1998) 2.10
Is there a T-cell form of chronic lymphocytic leukemia? Leukemia (1992) 2.08
Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med (1967) 2.06
Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease. J Clin Invest (1970) 2.04
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood (2001) 2.04
Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature (1987) 2.04
Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med (1983) 2.03
Thalassemia: the consequences of unbalanced hemoglobin synthesis. Am J Med (1966) 2.03
Opportunities for medical research in the 21st century. JAMA (2001) 2.01
Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med (1986) 1.99
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood (1994) 1.98
What's new in blood progenitor cell autotransplants? Bone Marrow Transplant (1994) 1.98
Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity. J Immunol (1975) 1.98
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98
Infection due to Corynebacterium species in marrow transplant patients. Ann Intern Med (1979) 1.94
Partial deletion of beta-globin gene DNA in certain patients with beta 0-thalassemia. Proc Natl Acad Sci U S A (1979) 1.94
Retinal abnormalities in diseases of the blood. Br J Ophthalmol (1969) 1.94
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis. Leukemia (2006) 1.92
Editors have ethical responsibilities, too. N Engl J Med (1984) 1.91